|
Sign In to gain access to subscriptions and/or personal tools.
|
New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis
Laura J Balcer
Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA, Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Monika L Baier
Department of Biostatistics, AMC Cancer Research Center, Denver, Colorado, USA
Victoria S Pelak
Department of Neurology, University of Colorado Health Sciences Center, Denver, Colorado, USA
Robert J Fox
Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Sarah Shuwairi
Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Steven L Galetta
Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA, Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Gary R Cutter
Department of Biostatistics, AMC Cancer Research Center, Denver, Colorado, USA
Maureen G Maguire
Department of Ophthalmology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA, Department of Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
The quantitative assessment of visual function in multiple sclerosis (MS) clinical trials has been limited to Snellen visual acuity. The purpose of this study was to examine the inter-rater reliability and test characteristics of a new visual outcome measure, the Low-Contrast Sloan Letter Charts, in patients with MS and visually-asymptomatic volunteers. Contrast letter acuity scores (letter scores) were measured at each of four contrast levels (100, 5, 1.25 and 0.6%) by two independent raters. Inter-rater agreement was described with the intraclass correlation coefficient (ICC) and comparison of mean scores. Excellent inter-rater agreement (ICC=0.86-0.95) was demonstrated at each contrast level among MS patients (n=100) and visually-asymptomatic volunteers (n=33). Average letter scores at the lowest contrast level (0.6%) were highly variable in the MS group, even among patients with visual acuities of 20/20 or better, and among those who required no assistance for ambulation. Low-Contrast Sloan Letter Chart testing is a highly reliable method of visual assessment, and provides information on an aspect of neurologic impairment in MS which is not captured by Snellen visual acuity or ambulation status. This new method demonstrates excellent potential as a visual function outcome measure for future MS clinical trials.
Key Words: vision contrast letter acuity multiple sclerosis MS reliability outcome measures
Multiple Sclerosis, Vol. 6, No. 3,
163-171 (2000)
DOI: 10.1177/135245850000600305

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Thurtell, E. Bala, S. S. Yaniglos, J. C. Rucker, N. S. Peachey, and R. J. Leigh
Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials
Neurology,
December 1, 2009;
73(22):
1849 - 1857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E M Mowry, M J Loguidice, A B Daniels, D A Jacobs, C E Markowitz, S L Galetta, M L Nano-Schiavi, G R Cutter, M G Maguire, and L J Balcer
Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity
J. Neurol. Neurosurg. Psychiatry,
July 1, 2009;
80(7):
767 - 772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Naismith, N. T. Tutlam, J. Xu, E. C. Klawiter, J. Shepherd, K. Trinkaus, S. K. Song, and A. H. Cross
Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis
Neurology,
March 24, 2009;
72(12):
1077 - 1082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Frohman, F. Costello, O. Stuve, P. Calabresi, D. H. Miller, S. J. Hickman, R. Sergott, A. Conger, A. Salter, K. H. Krumwiede, et al.
Modeling Axonal Degeneration Within the Anterior Visual System: Implications for Demonstrating Neuroprotection in Multiple Sclerosis
Arch Neurol,
January 1, 2008;
65(1):
26 - 35.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. D. Henderson, S. A. Trip, P. G. Schlottmann, D. R. Altmann, D. F. Garway-Heath, G. T. Plant, and D. H. Miller
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography
Brain,
January 1, 2008;
131(1):
277 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Wu, E. D. Schwartz, T. Lei, A. Souza, S. Mishra, D. A. Jacobs, C. E. Markowitz, S. L. Galetta, M. L. Nano-Schiavi, L. M. Desiderio, et al.
Relation of vision to global and regional brain MRI in multiple sclerosis
Neurology,
December 4, 2007;
69(23):
2128 - 2135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.A. Marrie and M. Goldman
Validity of performance scales for disability assessment in multiple sclerosis
Multiple Sclerosis,
November 1, 2007;
13(9):
1176 - 1182.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Leocani, E. Comi, P. Annovazzi, M. Rovaris, P. Rossi, M. Cursi, M. Comola, V. Martinelli, and G. Comi
Impaired Short-term Motor Learning in Multiple Sclerosis: Evidence From Virtual Reality
Neurorehabil Neural Repair,
May 1, 2007;
21(3):
273 - 278.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Balcer, S. L. Galetta, P. A. Calabresi, C. Confavreux, G. Giovannoni, E. Havrdova, M. Hutchinson, L. Kappos, F. D. Lublin, D. H. Miller, et al.
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
Neurology,
April 17, 2007;
68(16):
1299 - 1304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Lynch, J. M. Farmer, A. Y. Tsou, S. Perlman, S. H. Subramony, C. M. Gomez, T. Ashizawa, G. R. Wilmot, R. B. Wilson, and L. J. Balcer
Measuring Friedreich ataxia: Complementary features of examination and performance measures
Neurology,
June 13, 2006;
66(11):
1711 - 1716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Sisto, M. Trojano, M. Vetrugno, T. Trabucco, G. Iliceto, and C. Sborgia
Subclinical Visual Involvement in Multiple Sclerosis: A Study by MRI, VEPs, Frequency-Doubling Perimetry, Standard Perimetry, and Contrast Sensitivity
Invest. Ophthalmol. Vis. Sci.,
April 1, 2005;
46(4):
1264 - 1268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Baier, G. R. Cutter, R. A. Rudick, D. Miller, J. A. Cohen, B. Weinstock-Guttman, M. Mass, and L. J. Balcer
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis
Neurology,
March 22, 2005;
64(6):
992 - 995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Balcer, M. L. Baier, J. A. Cohen, M. F. Kooijmans, A. W. Sandrock, M. L. Nano-Schiavi, D. C. Pfohl, M. Mills, J. Bowen, C. Ford, et al.
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite
Neurology,
November 25, 2003;
61(10):
1367 - 1373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R A Rudick, G Cutter, and S Reingold
The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials
Multiple Sclerosis,
October 1, 2002;
8(5):
359 - 365.
[Abstract]
[PDF]
|
 |
|
|
|